
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $9.8M | -- | -- | -$0.18 | -- |
08/07/2025 | Q2 | $9.2M | -- | -- | -$0.20 | -- |
05/13/2025 | Q1 | $8.2M | $8.5M | -$0.22 | -$0.16 | -$0.06 |
02/26/2025 | Q4 | $8.2M | $7.8M | -$0.20 | -$0.16 | -$0.04 |
11/07/2024 | Q3 | $7.8M | $8.1M | -$0.18 | -$0.17 | -$0.01 |
08/07/2024 | Q2 | $7.3M | $7.9M | -$0.16 | -$0.18 | $0.02 |
05/07/2024 | Q1 | $7M | $7.6M | -$0.16 | -$0.19 | $0.03 |
03/12/2024 | Q4 | $6.5M | $6.8M | -$0.19 | -$0.20 | $0.01 |
11/09/2023 | Q3 | -- | -- | -$0.20 | -$0.25 | $0.05 |
08/08/2023 | Q2 | -- | -- | -$0.29 | -$0.19 | -$0.10 |
05/11/2023 | Q1 | -- | -- | -$0.23 | -$0.19 | -$0.05 |
03/01/2023 | Q4 | -- | -- | -$0.18 | -$0.20 | $0.02 |
11/08/2022 | Q3 | -- | -- | -$0.15 | -$0.19 | $0.04 |
08/09/2022 | Q2 | -- | -- | -$0.18 | -$0.19 | $0.01 |
05/11/2022 | Q1 | -- | -- | -$0.17 | -$0.20 | $0.03 |
03/01/2022 | Q4 | -- | -- | -$0.19 | -$0.19 | -- |
11/09/2021 | Q3 | -- | -- | -$0.18 | -$0.16 | -$0.02 |
08/10/2021 | Q2 | -- | -- | -$0.17 | -$0.14 | -$0.04 |
05/11/2021 | Q1 | -- | -- | -$0.13 | -$0.15 | $0.02 |
03/04/2021 | Q4 | -- | -- | -$0.09 | -$0.13 | $0.04 |
11/10/2020 | Q3 | -- | -- | -$0.09 | -$0.16 | $0.07 |
08/12/2020 | Q2 | -- | -- | -$0.11 | -$0.18 | $0.07 |
05/12/2020 | Q1 | -- | -- | -$0.13 | -- | -- |
12/31/2019 | Q4 | -- | -- | -$0.11 | -- | -- |
09/30/2019 | Q3 | -- | -- | -$0.08 | -- | -- |
09/30/2015 | Q3 | -- | -- | -$1.20 | -$1.00 | -$0.20 |
ClearPoint Neuro reported $8.5M worth of top line sales in its most recent quarter.
ClearPoint Neuro announced earnings per share of -$0.22 which represents a miss of analyst forecast a -$0.16 per share.
ClearPoint Neuro reported $5.1M that represents $0.19 per share over the last quarter.
ClearPoint Neuro's earnings are forecast to decrease from -$0.70 per share to -$0.67 per share next year representing a decrease of -10%.
ClearPoint Neuro's next earnings date is August 7, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.